Another anti-interleukin (IL)-17 inhibitor: is there an advantage of blocking IL-17A and IL-17F?

被引：0
|
作者：
Gerdes, Sascha [1 ]
Albrecht, Joerg [2 ,3 ]
机构：
[1] Univ Med Ctr Schleswig Holstein, Psoriasis Ctr Kiel, Dept Dermatol, Campus Kiel, Kiel, Germany
[2] John H Stroger Jr Hosp Cook Cty, Div Dermatol, Dept Med, Chicago, IL USA
[3] Rush Med Coll, Div Dermatol, Dept Otorhinolaryngol, Chicago, IL 60612 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 04期
关键词：
D O I：
10.1111/bjd.20959
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [41] Association analysis of IL-17A and IL-17F polymorphisms in Chinese women with cervical cancer
    Li, L.
    Tian, Y. L.
    Lv, X. M.
    Yu, H. F.
    Xie, Y. Y.
    Wang, J. D.
    Shi, W.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 12178 - 12183
  • [42] Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F
    Nakanishi, Takehisa
    Iida, Shohei
    Maruyama, Junko
    Urushima, Hayato
    Ichishi, Masako
    Matsushima, Yoshiaki
    Mizutani, Kento
    Nakayama, Yuichi
    Sugioka, Kyoko
    Nishimura, Mai
    Umaoka, Ai
    Iwakura, Yoichiro
    Kondo, Makoto
    Habe, Koji
    Tsuruta, Daisuke
    Yamamoto, Osamu
    Imai, Yasutomo
    Yamanaka, Keiichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [43] Assessing the effects of IL-17A and IL-17F dual inhibition with bimekizumab on the psoriasis transcriptome
    Cutcutache, I.
    Edwards, H.
    Garcet, S.
    Krueger, J.
    Page, M.
    Shaw, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S110 - S110
  • [44] Arteriosclerosis derived from cutaneous inflammation is ameliorated by the deletion of IL-17A or IL-17F
    Nakanishi, T.
    Iida, S.
    Matsushima, Y.
    Mizutani, K.
    Nakayama, Y.
    Sugioka, K.
    Nishimura, M.
    Umaoka, A.
    Kondo, M.
    Habe, K.
    Yamanaka, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S13 - S13
  • [45] Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis
    McLean, Leon P.
    Cross, Raymond K.
    Shea-Donohue, Terez
    IMMUNOTHERAPY, 2013, 5 (09) : 923 - 925
  • [46] Interleukin (IL)-12 and IL-18 Synergize to Promote MAIT Cell IL-17A and IL-17F Production Independently of IL-23 Signaling
    Cole, Suzanne
    Murray, Janine
    Simpson, Catherine
    Okoye, Remi
    Tyson, Kerry
    Griffiths, Meryn
    Baeten, Dominique
    Shaw, Stevan
    Maroof, Asher
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [47] IL-17A and IL-17F polymorphisms in rheumatoid arthritis and Sjögren’s syndrome
    Camila Nunes Carvalho
    Rodrigo Feliciano do Carmo
    Angela Luzia Pinto Duarte
    Alessandra Albuquerque Tavares Carvalho
    Jair Carneiro Leão
    Luiz Alcino Gueiros
    Clinical Oral Investigations, 2016, 20 : 495 - 502
  • [48] Small molecule inhibitors of IL-17A and IL-17F secretion for the treatment of autoimmune diseases
    Tasler, Stefan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [49] Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
    Lisa GM van Baarsen
    Maria C Lebre
    Dennis van der Coelen
    Saïda Aarrass
    Man W Tang
    Tamara H Ramwadhdoebe
    Daniëlle M Gerlag
    Paul P Tak
    Arthritis Research & Therapy, 16
  • [50] Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
    Hot, Arnaud
    Miossec, Pierre
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) : 727 - 732
12345